Join us as we go over our top stories from the week:
Clinical Research as a Care Option a Must for Oncology Practices, According to Bradley Prechtl.
Ellis Fischel Cancer Center Clinical Research as a Care Option Saved Mom from Breast Cancer.
Odonate Therapeutics Announces Patient Enrollment Completion for CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer.
Estee Lauder Chairman Gifts $5M to University of Arizona’s David Alberts to Advance Ovarian Cancer Research.
BEACON Trial in Colorectal Cancer Called “Single Worst Reported” From Critic.
Therapy Advancements and Biomarker Identifications Leading to Improved Ability to Predict and Enhance Responses To Immunotherapeutic Agents In Non–Small Cell.
New Smartphone App to Match Metastatic Breast Cancer Patients with Clinical Trials.
Northwestern Medicine Team Eliminate Parkinson’s Disease Symptoms in Human Brain Cells & Mouse Models.
Spinocerebellar Ataxia (SCA) Clinical Trial Assessing Safety and Efficacy of Troriluzole.
Saudi Arabia Needs to Develop its Clinical Trials Capacity & Competencies for Health Benefits to its People.
Biogen Announces Pursual of FDA Approval for Aducanumab.
UC San Diego’s Center for Medicinal Cannabis Research Awards 5 Investigators $3M for Clinical Studies.
Bermekimab Appears to Do Well in a Phase II Study for Atopic Dermatitis Patients.